Medical Product Guide» TetraLogic Pharmaceuticals http://blog.medicalproductguide.com A comprehensive guide to medical products for medical professionals Mon, 20 Jun 2011 12:36:09 +0000 en hourly 1 http://wordpress.org/?v=3.1.3 TetraLogic Pharmaceuticals Initiates Phase 1 Clinical Trial Of TL32711 In Patients With Refractory Solid Tumors Or Lymphoma http://blog.medicalproductguide.com/2010/01/18/tetralogic-pharmaceuticals-initiates-phase-1-clinical-trial-tl32711-patients-refractory-solid-tumors-lymphoma/ http://blog.medicalproductguide.com/2010/01/18/tetralogic-pharmaceuticals-initiates-phase-1-clinical-trial-tl32711-patients-refractory-solid-tumors-lymphoma/#comments Mon, 18 Jan 2010 15:30:57 +0000 Jim Marino http://www.medicalproductguide.com/blog/?p=416 TetraLogic PharmaceuticalsTetraLogic Pharmaceuticals announced that the Company has completed dosing of the first cohort in a Phase 1 clinical trial of its selective SMAC mimetic, TL32711. The Phase 1 trial is an open-label, dose-escalation study evaluating the safety and tolerability of TL32711 in adults with solid tumors or lymphoma refractory to standard therapies. The study will also assess the pharmacokinetics, pharmacodynamics and anti-tumor activity of TL32711.

For the full story, Click Here

]]> http://blog.medicalproductguide.com/2010/01/18/tetralogic-pharmaceuticals-initiates-phase-1-clinical-trial-tl32711-patients-refractory-solid-tumors-lymphoma/feed/ 0